Effects of thymic selection on T cell recognition of foreign and tumor antigenic peptides

Jason T George1,2,3, David A Kessler4, Herbert Levine1,2,5

  • 1Center for Theoretical Biological Physics, Rice University, Houston, TX 77005; jason.george@rice.edu herbert.levine@rice.edu.

Insights

Cancer immunotherapy harnesses cytotoxic T lymphocytes (CTLs) to target tumor-associated neoantigens (TANs). This study models T cell selection, revealing that thymic selection thresholds optimize CTLs for recognizing foreign antigens and surviving selection.

Area of Science:

  • Immunology
  • Computational Biology
  • Oncology

Background:

  • Cancer immunotherapy offers novel strategies by leveraging the immune system, particularly cytotoxic T lymphocytes (CTLs).
  • Current optimization of immunotherapies relies heavily on empirical approaches rather than predictive models.
  • CTLs recognize tumor-associated neoantigens (TANs) similarly to foreign peptides presented on cell surfaces.

Purpose of the Study:

  • To develop a predictive model for T cell selection in cancer immunotherapy.
  • To analytically study the impact of selection on CTL recognition of TANs and foreign peptides.
  • To estimate the number of CTLs capable of detecting donor-matched transplants.

Main Methods:

  • Development of a mathematical model for T cell selection based on random interaction strengths between self-peptides and T cell receptors.
  • Analytical study of selection effects on CTL recognition of TANs and foreign peptides.
  • Simulation to confirm analytical results and validate the model's predictions.

Main Results:

  • The model demonstrates that negative selection thresholds, aligned with experimental thymic survival rates, lead to near-optimal T cell production.
  • Optimized T cells exhibit enhanced survival post-selection and improved recognition of foreign antigens.
  • The model provides a framework for estimating CTLs capable of recognizing donor-matched transplants.

Conclusions:

  • The developed model provides an analytical approach to understanding T cell selection in immunotherapy.
  • Experimentally observed thymic survival rates correlate with optimal T cell production for immunotherapy.
  • This work offers a foundation for moving beyond empirical optimization in cancer immunotherapy development.

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.7K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.6K